Description
Xcel Pharma XP – TESA contains Tesamorelin, a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). Tesamorelin is primarily known for research and clinical use involving growth-hormone signaling and body-composition parameters.
Each vial contains 2 mg of Tesamorelin, with the product supplied as a five-vial pack along with bacteriostatic water ampoules.
Benefits
- Contains Tesamorelin, a GHRH analogue
- Studied for its effects on growth-hormone signaling
- Associated with research into body-composition changes
- Used in clinical research involving visceral adipose tissue
- Convenient 2 mg vial presentation
- Five-vial pack
- Includes bacteriostatic water ampoules
- Manufactured under the Xcel Pharma brand
Product Overview
XP – TESA contains Tesamorelin, a synthetic analogue of growth hormone-releasing hormone. Tesamorelin works by stimulating the pituitary gland to increase the release of growth hormone, which can subsequently influence downstream IGF-1 levels.
Tesamorelin has been studied particularly in relation to visceral adipose tissue, making it a compound of interest in body-composition research. Its effects are different from directly administering growth hormone because it works through the body’s own growth-hormone release pathway.
Tesamorelin is a hormone-active peptide and can affect glucose metabolism, IGF-1 levels, fluid balance, and other physiological processes. Medical supervision is appropriate when it is being considered for therapeutic use.
Product Composition
- Active Compound: Tesamorelin
- Potency: 2 mg/vial
- Form: Lyophilized peptide
- Pack: 2 mg vial × 5 vials
- Bacteriostatic Water: 2 mL × 5 ampoules
- Packaging: Security seal label and packed box
- Brand: Xcel Pharma
Product Details
XP – TESA is supplied as a five-vial peptide pack, with each vial containing 2 mg of Tesamorelin. The package also includes five 2 mL bacteriostatic water ampoules for product preparation.
Reviews
There are no reviews yet.